We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.35 | 1.93% | 18.44 | 16.86 | 18.44 | 18.44 | 18.44 | 18.44 | 327,233 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 14.57 | 5.02B |
TIDMGLB
RNS Number : 9513J
Glanbia PLC
03 May 2022
Glanbia plc Transaction in Own Shares Glanbia plc ("Glanbia" or the "Company"), the Global Nutrition Group, announces that on Friday, 29 April, 2022 it purchased the following number of its ordinary shares (the "Ordinary Shares") on Euronext Dublin, via Glanbia's broker J&E Davy. The Ordinary Shares purchased will be cancelled. ----------------------------------------------------------------------------------------------- Euronext Dublin --------------------------------- Number of Ordinary Shares purchased 127,677 --------------------------------- Highest price paid per Ordinary Share EUR 11.4100 --------------------------------- Lowest price paid per Ordinary Share EUR 11.3000 --------------------------------- Volume weighted average price paid per Ordinary Share EUR 11.4030 --------------------------------- The Ordinary Shares purchased form part of Glanbia's intention to buy back the Company's Ordinary Shares of a total value of up to EUR50 million in the period up to the Company's annual general meeting in 2022 ("Buy-Back Programme"). This Buy-Back Programme was announced on 03 March 2022 and formally commenced on that date. Following settlement of the above transactions and subsequent share cancellation Glanbia will hold 276,588,475 ordinary shares in issue. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), a detailed breakdown of individual trades made by Davy on behalf of Glanbia as part of the buyback programme is scheduled to this announcement. Contact: Liam Hennigan Group Director Strategic Planning and Investor Relations Tel: 00 353 86 046 8375 Olivia Kennington Deputy Group Secretary Tel: 00 35356 777 2200 Issuer name: Glanbia plc ------------- LEI 635400SRMCBHVMSKJS84 ------------- ------------ -------------------------------------------- ISIN: IE0000669501 ------------- ------------ -------------------------------------------- Intermediary name: J&E Davy --------------------------- -------------------------------------------- Intermediary code: DAVYIE21 --------------------------- ------------- ----------------------------- Time zone: GMT ------------- ------------ ------------- ----------------------------- Currency: EUR ------------- ------------ -------------------------------------------- Aggregated Information Trading venue Currency Volume Weighted Aggregated Average Price volume ----------------------------- Euronext Dublin EUR EUR 11.4030 127,677 --------------------------- ------------- ----------------------------- Euronext Dublin Number of Price Per Currency Trade Time Trading Venue MatchID Shares Share (EUR) Euronext 5000 11.3 EUR 13:25:09 Dublin 00037626080TRLO0-1 ------------ ------------- -------------- ------------- ------------------ Euronext 5000 11.35 EUR 14:42:39 Dublin 00037627202TRLO0-1 ------------ ------------- -------------- ------------- ------------------ Euronext 5000 11.4 EUR 15:13:02 Dublin 00037627795TRLO0-1 ------------ ------------- -------------- ------------- ------------------ Euronext 112677 11.41 EUR 15:28:38 Dublin 00037628223TRLO0-1 ------------ ------------- -------------- ------------- ------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSBLGDSCDDDGDC
(END) Dow Jones Newswires
May 03, 2022 02:01 ET (06:01 GMT)
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions